<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Meyers Aircraft Owners Association | Duran Henry | Activity</title>
	<link>https://www.meyersaircraft.org/members/fightjeep12/activity/</link>
	<atom:link href="https://www.meyersaircraft.org/members/fightjeep12/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Duran Henry.</description>
	<lastBuildDate>Wed, 08 Apr 2026 15:04:01 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">4974d2941110abc44c82255a621fbdd6</guid>
				<title>Duran Henry posted an update: Right here, we evaluated the actual specialized medical [&#133;]</title>
				<link>https://www.meyersaircraft.org/activity/p/4202/</link>
				<pubDate>Sun, 18 Sep 2022 08:47:21 +0000</pubDate>

									<content:encoded><![CDATA[<p>Right here, we evaluated the actual specialized medical efficacy of CD8(+) T-cell identical dwellings certain to the melanocyte differentiation antigens (MDA), gp100 as well as MART-1, respectively. Experimental Design: We all executed 2 sequential cycle The second clinical trials relating to the adoptive change in very Lenvatinib selected&hellip;<span class="activity-read-more" id="activity-read-more-4202"><a href="https://www.meyersaircraft.org/activity/p/4202/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4d7d380ba12d80b283802af0956e504c</guid>
				<title>Duran Henry became a registered member</title>
				<link>https://www.meyersaircraft.org/activity/p/3549/</link>
				<pubDate>Thu, 15 Sep 2022 07:43:47 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>